{"organizations": [], "uuid": "15810862476e2228a963e0647679b40c4157b0f5", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "", "site_section": "http://www.reuters.com/finance/personal-finance", "section_title": "Wealth, Personal Finance &amp; Money | Reuters.com", "url": "http://www.reuters.com/article/2015/08/10/idUSFWN10K00R20150810", "country": "US", "title": "BRIEF-Astrazeneca in cancer vaccine collaboration with Medimmune", "performance_score": 0, "site": "reuters.com", "participants_count": 1, "title_full": "BRIEF-Astrazeneca in cancer vaccine collaboration with Medimmune | Reuters", "spam_score": 0.0, "site_type": "news", "published": "2015-08-10T11:04:00.000+03:00", "replies_count": 0, "uuid": "15810862476e2228a963e0647679b40c4157b0f5"}, "author": "Reuters", "url": "http://www.reuters.com/article/2015/08/10/idUSFWN10K00R20150810", "ord_in_thread": 0, "title": "BRIEF-Astrazeneca in cancer vaccine collaboration with Medimmune", "locations": [], "entities": {"persons": [], "locations": [], "organizations": []}, "highlightText": "", "language": "english", "persons": [], "text": "Aug 10 Astrazeneca Plc\n* Medimmune enters into strategic cancer vaccine collaboration and license agreement with inovio pharmaceuticals\n* Medimmune will make an upfront payment of $27.5 million to inovio as well as potential future payments upon reaching development\n* Agreement includes clinical-stage ino-3112 hpv cancer vaccine and preclinical collaboration to develop additional cancer vaccine candidates 10 august 2015\n* Medimmune will fund all development costs Source text for Eikon: Further company coverage: (Bengaluru Newsroom; +44 207 542 1810)", "external_links": [], "published": "2015-08-10T11:04:00.000+03:00", "crawled": "2015-08-10T10:08:28.618+03:00", "highlightTitle": ""}